Tagma Pharma (Uk) Ltd - Accounts to registrar (filleted) - small 18.1

Tagma Pharma (Uk) Ltd - Accounts to registrar (filleted) - small 18.1


IRIS Accounts Production v18.1.0.975 05797558 director 1.5.17 30.4.18 30.4.18 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure057975582017-04-30057975582018-04-30057975582017-05-012018-04-30057975582016-04-30057975582016-05-012017-04-30057975582017-04-3005797558ns15:EnglandWales2017-05-012018-04-3005797558ns14:PoundSterling2017-05-012018-04-3005797558ns10:Director12017-05-012018-04-3005797558ns10:PrivateLimitedCompanyLtd2017-05-012018-04-3005797558ns10:Micro-entities2017-05-012018-04-3005797558ns10:AuditExempt-NoAccountantsReport2017-05-012018-04-3005797558ns10:FullAccounts2017-05-012018-04-3005797558ns5:CurrentFinancialInstruments2018-04-3005797558ns5:CurrentFinancialInstruments2017-04-30


REGISTERED NUMBER: 05797558 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2018

for

Tagma Pharma (Uk) Ltd

Tagma Pharma (Uk) Ltd (Registered number: 05797558)






Contents of the Financial Statements
for the Year Ended 30 April 2018




Page

Balance Sheet 1


Tagma Pharma (Uk) Ltd (Registered number: 05797558)

Balance Sheet
30 April 2018

30.4.18 30.4.17
£    £    £    £   
FIXED ASSETS 25 34

CURRENT ASSETS 3,251 2,103

CREDITORS
Amounts falling due within one year (497 ) (281 )
NET CURRENT ASSETS 2,754 1,822
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,779

1,856

CAPITAL AND RESERVES 2,779 1,856

NOTE TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Tagma Pharma (Uk) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered
number and registered office address are as below:

Registered number: 05797558

Registered office: Morgan Reach House
136 Hagley Road
Birmingham
West Midlands
B16 9NX




The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable
to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the director on 2 May 2018 and were signed by:



N H Shaikh - Director